Skip to main content
Medical information Clinical review pending

Genetic Testing

Chr 11p15 Gene Beckwith-Wiedemann Syndrome Genetic Test

Genetic test using Next-Generation Sequencing (NGS) to analyze the chr 11p15 gene, associated with Beckwith-Wiedemann Syndrome and increased cancer risk. Recommended for individuals with a family history or symptoms.

General information only: This page is not a diagnosis or personal medical advice. A qualified clinician should decide whether testing is appropriate and interpret results in context.

Review status: No completed medical review is recorded for this page.

Ask a question
Counselor guidance included Confidential handling Kenya-wide coordination

At a glance

Plan your test

Sample
Blood sample (EDTA tube) or Saliva sample (specific collection kit). Confirm with the laboratory before booking.
Results
3 to 4 weeks. Confirm with the laboratory before booking.
Preparation
No specific fasting is required. Follow instructions provided by the laboratory regarding sample collection.
Test priceKSh 40,000

Payment: M-Pesa and card options can be confirmed during booking.

Insurance & government schemes

Is this test covered for you?

We help you verify whether the Chr 11p15 Gene Beckwith-Wiedemann Syndrome Genetic Test test can be claimed against your insurer, employer scheme or a Kenyan government health scheme — before you book. Coverage depends on your plan, clinical indication and your provider's rules; final approval always rests with them.

Talk to a claims advisor

Providers & schemes we can help you check

Government & public schemes

SHIF — Social Health Insurance Fund Linda Mama EduAfya NHIF (legacy cards)

Eligibility and benefits follow the current rules of the Social Health Authority (SHA) and applicable government programmes.

Private insurers & employer schemes

Jubilee Health AAR APA Britam CIC Madison Resolution Pioneer Minet Old Mutual GA Life Heritage + other licensed insurers

Names shown for identification only — listing does not imply partnership or guarantee of coverage.

Have these ready when we check

  • Insurer or scheme name & policy / member number
  • A clinician's request / prescription for the test
  • Pre-authorisation letter, if your plan requires one

Free coverage check

Ask us to verify your cover

Send your details and our claims team confirms what documents you need and whether pre-authorisation applies — usually the same working day.

+254

Used only to process your coverage check — see our Privacy Policy. Verification support is free and does not guarantee your provider will pay.

01

Start with fit

Is this the right test for you?

The best test starts with a clear clinical question. These are common reasons a clinician or family may consider this test.

  • ✓Family history of Beckwith-Wiedemann Syndrome
  • ✓Symptoms suggestive of Beckwith-Wiedemann Syndrome
  • ✓Assessment of genetic risk for associated cancers
  • ✓Personal history of related conditions
02

In plain language

What this test helps you understand

Identifies genetic variations in the chr 11p15 gene associated with Beckwith-Wiedemann Syndrome, which carries an increased risk for certain childhood cancers. Helps assess individual risk and guide management.
The Chr 11p15 Gene Beckwith-Wiedemann Syndrome NGS Genetic DNA Test is an advanced diagnostic tool designed to identify genetic predispositions to Beckwith-Wiedemann Syndrome, a condition associated with an increased risk of various cancers. This test utilizes Next-Generation Sequencing (NGS) technology, providing a comprehensive analysis of the genetic markers linked to this syndrome. Understanding your genetic makeup is crucial for early detection and intervention, especially for individuals with a family history of cancer.

This genetic test specifically measures variations in the chr 11p15 gene, which are associated with Beckwith-Wiedemann Syndrome. By analyzing these genetic markers, healthcare providers can assess an individual’s risk of developing related health issues, including certain types of cancer.

Taking this test offers several advantages, including early detection of genetic predispositions to cancer, allowing for timely interventions, informed decision-making regarding health management and preventive measures, and access to personalized medical care based on genetic findings.

Results from the Chr 11p15 Gene Beckwith-Wiedemann Syndrome NGS Genetic DNA Test will be provided within 3 to 4 weeks. It is important to consult with a genetic counselor or healthcare provider to interpret the results accurately. They will help you understand the implications of your genetic profile and discuss potential next steps.
03

Medical review status

Clinical review pending

A completed medical review is not recorded for this page. No clinician has endorsed the information shown here. Please discuss testing decisions with a qualified healthcare professional.

Meet the DNA Labs Kenya medical team →
04

A simple process

What happens next?

You do not have to navigate the test alone. We help you move from question to next step.

1

Speak with us

We check the test and answer your questions before collection.

2

Give your sample

Choose home collection or a coordinated hub visit in Kenya. We explain whether this test uses a cheek swab or blood draw.

3

Understand your report

A counselor helps you understand the result and the next steps.

05

Choose your collection

Home collection or a lab visit

We will explain the sample, preparation, and next steps before anything is collected.

Home collection

Choose a coordinated visit at home or another convenient location. Our team confirms the appointment and sample requirements in advance.

Lab or hub visit

Prefer to visit a coordinated location? We can guide you to the right hub and explain what to expect when you arrive.

Ask about locations →
PreparationNo specific fasting is required. Follow instructions provided by the laboratory regarding sample collection.
SampleBlood sample (EDTA tube) or Saliva sample (specific collection kit). Confirm with the laboratory before booking.
MethodologyNext-Generation Sequencing (NGS) analysis of the chr 11p15 gene region.
PrivacyYour sample and report are handled confidentially. Ask the team how your information is stored and shared.
This test analyzes specific variations in the chr 11p15 gene. It may not detect all genetic changes associated with Beckwith-Wiedemann Syndrome or related conditions. Results should be interpreted alongside clinical information. Confirm with the laboratory before booking.
06

Read your report

What common result terms mean

PositiveA finding was identified. Your clinician or counselor will explain what it means for your care.
NegativeThe specific finding tested for was not identified. It does not rule out every possible cause.
VUSA variant was found, but current evidence is not enough to classify it. Your counselor can explain follow-up.
07

Questions people ask

Frequently asked questions

Beckwith-Wiedemann Syndrome is a genetic disorder that causes excessive growth before and after birth. It is associated with an increased risk of developing certain types of childhood cancers.
Individuals with a family history of Beckwith-Wiedemann Syndrome, those showing symptoms of the syndrome, or those seeking to understand their genetic risk for associated cancers may benefit from this test.
A sample is typically collected via a blood draw or a saliva sample using a specific kit. Please confirm the required sample type with the laboratory.
The turnaround time for results is typically 3 to 4 weeks. Confirm with the laboratory before booking.
It is recommended to discuss your results with a genetic counselor or healthcare provider. They can help interpret the findings and discuss any implications for your health or your family's health.
08

Collaboration

Open for partnership with hospitals, clinics, doctors & researchers

Whether you are referring patients, building a research programme or supporting students, we work as an extension of your team — with responsive communication and clear scientific standards.

Hospitals & clinics

Referral pathways, coordinated sample logistics and shared reporting that fits your clinical workflow.

Doctors & specialists

LOINC-coded reports, ACMG-based variant classification and a direct scientific line for complex cases.

Research institutions

Sanger sequencing, NGS panels and custom assays — with project design support, batch pricing and agreed turnaround commitments.

Students & academic projects

Discounted laboratory services for college, master's and PhD research projects — including proposal guidance and cost-effective batch testing.

Explore partnerships
09

Trust & transparency

Sources, standards & how this page is maintained

Standards & references

  • ACMG/AMP technical standards for sequence variant interpretation
  • ClinGen curation and gene–disease validity frameworks where applicable
  • LOINC-coded reporting for interoperable results
  • ISO 9001:2015 quality management; ISO 15189 accreditation in progress

Page provenance

  • Last updated: September 27, 2026
  • Medical review: not yet completed
  • Written for patients & clinicians in Kenya; reviewed periodically against current guidance

Medical disclaimer: this page is general information, not a diagnosis or personal medical advice. Testing decisions and result interpretation should be made with a qualified healthcare professional.

Keep exploring

Related tests

View all tests →
Chat on WhatsApp